CASE HISTORIES
Morganceutical has developed numerous collaborations with leading Companies in the Healthcare sector
Years
0
Collaborations
0
Products
0
AMs / REPs hired
0
General Practitioners contacted
0
Specialists contacted
0
WOULD YOU LIKE TO RECEIVE MORE INFORMATION?
leave us your contact details and we will contact you as soon as possible
CONTACT USSOME RELEVANT PHARMACEUTICAL PRODUCTS WE HAVE MANAGED
| Year (Morganceutical activity start) | Product typology | Sales volume (units/year) |
| 2010 | PPI Originator | 1,5 MM |
| 2014 | Alpha-blocker (prostatic hypertrophy) | 4,3 MM |
| 2015 | SSRI Originator | 2,3 MM |
| 2016 | Quinolone Originator | 1,2 MM |
| 2017 | Iron++, Folic Acid | 8,2 MM (total) |
| 2020 | LAMA | 1,7 MM |
| Typology | N. Collaborations |
| Big Pharma | 2 |
| Large Multinational Companies | 5 |
| Multinationals average turnover (30-120MM /year in Italy) | 9 |
| Multinational generic pharmaceutical companies with branded products | 2 |
| High turnover Italian companies | 4 |
| Others | 10 |
MAIN TYPES OF PARTNER COMPANIES
CASE HISTORY 1


CASE HISTORY 2
CASE HISTORY 3


CASE HISTORY 4 A
CASE HISTORY 4 B

